4 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 10.0% per year over the past 3 years.
Operating margin has contracted, at -219.4% in the latest year.
Financial health
Operating income covered interest expense -105.9× in the latest year, down from -10.6× 3 years ago.
The company is unprofitable and has less than a year of cash runway at its current free-cash-flow burn.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
2025
$4M
-$8M
84.2%
-219.4%
-229.5%
-121.8%
-$6M
—
$5M
2024
$3M
-$8M
86.5%
-266.5%
-398.6%
-173.2%
-$6M
—
$4M
2023
$2M
-$15M
87.7%
-270.9%
1042.4%
-2870.8%
-$7M
—
$78560
2022
$3M
-$5M
88.9%
-125.6%
85.8%
-322.8%
-$2M
$228342
$253699
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
Jun '26
$2M
-$2M
85.9%
-110.2%
-31.0%
-20.9%
—
—
$8M
Mar '26
$2M
-$2M
86.4%
-108.3%
-30.6%
-20.1%
—
—
$7M
Dec '25
$968127
-$2M
85.4%
-177.3%
-50.3%
-26.7%
-$2M
—
$5M
Sep '25
$811414
-$2M
83.3%
-258.8%
-92.9%
-36.7%
-$1M
—
$4M
Jun '25
$894086
-$2M
83.6%
-192.1%
-39.7%
-23.8%
-$1M
—
$6M
Mar '25
$895655
-$2M
84.4%
-256.2%
-881.6%
-75.2%
-$2M
—
$2M
Dec '24
$761165
-$1M
86.2%
-192.7%
-70.0%
-30.4%
-$2M
—
$4M
Sep '24
$666625
-$2M
85.4%
-247.7%
97.8%
-153.5%
-$1M
—
$260885
Jun '24
$611500
-$3M
88.0%
-360.9%
55.5%
-110.8%
-$2M
—
$2M
Mar '24
$646635
-$2M
88.4%
-283.3%
66.6%
-224.2%
-$1M
—
$81752
Dec '23
$531459
-$2M
86.4%
-305.4%
113.5%
-312.5%
-$3M
—
$78560
Sep '23
$477460
-$9M
85.9%
-633.0%
812.9%
-697.9%
-$3M
—
$761249
Jun '23
$646021
-$2M
89.5%
-173.0%
22.4%
-145.2%
-$629684
—
$51440
Mar '23
$805110
-$2M
88.1%
-111.3%
28.1%
—
-$630520
—
—
Dec '22
$613082
-$13628
87.7%
-160.9%
0.2%
-0.9%
-$204315
$228342
$253699
Sep '22
$618805
-$2M
89.1%
-194.4%
37.4%
—
—
—
—
Jun '22
$682581
-$2M
88.4%
-98.1%
43.5%
—
—
—
—
Mar '22
—
-$1M
—
—
59.0%
—
—
—
—
Valuation over time
How the market has priced NRXS against its own fundamentals since 2023-08 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-sales ratio has risen from 19.9× (Aug '23) to 21.2× (Sep '26).
Price / sales (P/S)
P/S
Frequently asked questions
Is NRXS growing its revenue and profit?
Over the past 3 years, Neuraxis, INC's revenue has grown 10.0% per year. These are computed facts, not advice.
How much debt does NRXS have?
As of FY2025, Neuraxis, INC reported — of total debt against $5M of cash; operating income covered interest expense -105.9×.
What is NRXS's profit margin?
In FY2025, gross margin was 84.2%, operating margin -219.4%, and net margin -218.5%.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.